The historic rise of Viagra has long been a benchmark of pharmaceutical success, but its legacy within the broader sector now triggers questions about future yields . Copycat versions are undercutting https://dftsocial.com/story22581291/the-blue-diamond-and-pharma-a-precarious-opportunity